MBX Biosciences to take part in upcoming investor conferences
MBX Biosciences says it will participate in upcoming investor conferences. The company is a clinical-stage biopharmaceutical focused on precision peptide therapies for endocrine and metabolic disorders.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.